CasLoc logo
All Cases PTAB Litigations UPC Oppositions
Patent maintained as amended Patent maintained as amended, The patent has been granted, Grant of patent is intended, Examination is in progress, Request for examination was made, The application has been published EP Register Verified

DISPLAYS FOR A GLUCOSE MONITORING SYSTEM

Publication No. EP3988471
•
App No. EP21209431
•
Filed by Abbott Diabetes Care, Inc.
•
Filed on 2010-08-30
•
Issued/Published on 2025-10-15
Publication No. EP3988471 A1
Application No. EP21209431 Filed: 2010-08-30
Grant Date 2010-08-30 Mention of grant
Active Oppositions 1 Active EPO Oppositions

Patent Abstract / Summary

Embodiments described herein relate to a glucose monitoring system having a glucose sensor positioned in contact with interstitial fluid in a body of a user. A transmitter unit is coupled to the glucose sensor and processes data indicative of a plurality of monitored glucose levels from the glucose sensor. A receiver unit receives the processed data from the transmitter unit. The receiver unit comprises a processor and a user interface having a touch-sensitive display to render a plurality of display screens, including a home screen and an alert screen. The home screen is divided into a plurality of simultaneously displayed panels, with a first panel displaying the plurality of monitored glucose levels, a second panel simultaneously displaying a current glucose level icon and a glucose trend indicator, and a third panel displays status information of a plurality of components of the system. When an alarm condition is detected in response to the current glucose level being outside predetermined threshold levels, the display renders the alert screen on the display. The alert screen displays information corresponding to the detected alarm condition. The display affects a further output corresponding to the detected condition in response to user actuation of a portion of the display. The current glucose level icon is displayed in a colour coded format based on whether the current glucose level is within or outside the predetermined threshold levels.

IPC Classifications

B65D81/00, A61B5/00

Priority Claims

US 20090238657P Date: 2009-08-31
US 200923867209P Date: 2009-08-31
US 20090247541P Date: 2009-09-30
US 20100297625P Date: 2010-01-22

Designated Contracting States (37 EPC States)

Albania Albania (AL) Austria Austria (AT) Belgium Belgium (BE) Bulgaria Bulgaria (BG) Switzerland Switzerland (CH) Cyprus Cyprus (CY) Czech Republic Czech Republic (CZ) Germany Germany (DE) Denmark Denmark (DK) Estonia Estonia (EE) Spain Spain (ES) Finland Finland (FI) France France (FR) United Kingdom United Kingdom (GB) Greece Greece (GR) Croatia Croatia (HR) Hungary Hungary (HU) Ireland Ireland (IE) Iceland Iceland (IS) Italy Italy (IT) Liechtenstein Liechtenstein (LI) Lithuania Lithuania (LT) Luxembourg Luxembourg (LU) Latvia Latvia (LV) Monaco Monaco (MC) North Macedonia North Macedonia (MK) Malta Malta (MT) Netherlands Netherlands (NL) Norway Norway (NO) Poland Poland (PL) Portugal Portugal (PT) Romania Romania (RO) Sweden Sweden (SE) Slovenia Slovenia (SI) Slovakia Slovakia (SK) San Marino San Marino (SM) Turkey Turkey (TR)

Parties & Representation

Applicants

Abbott Diabetes Care, Inc.

1360 South Loop Road, Alameda, CA 94502

US

Inventors (14)

HARPER, Wesley Scott

California, 94502

US

TAN, Annie

California, 94065

US

DUNN, Timothy Christian

California, 94117

US

SLOAN, Mark Kent

California, 94065

US

DONIGER, Kenneth

California, 94025

US

MCGARRAUGH, Geoffrey

California, 94105

US

LOVE, Michael

California, 94566

US

YEE, Phillip

California, 94122

US

HAYTER, Gary Alan

California, 94618

US

TAUB, Marc Barry

California, 94040

US

PEYSER, Thomas

California, 94025

US

PANI, Michael

64372 Ober-Ramstadt

DE

JENNEWINE, Curtis

California, 94111

US

BERMAN, Glenn Howard

California, 94502

US

Representatives / Agents

Warren, Caroline Elisabeth

Mathys & Squire The Shard, 32 London Bridge Street

GB

Hoffmann Eitle

Patent- und Rechtsanwälte PartmbB, Arabellastraße 30

DE

Key Procedural Dates

Request-For-Examination 2022-09-27
Mention Of Grant Published 2010-08-30
Patent-Maintained-As-Amended 2025-10-15
First-Examination-Report-Despatched 2022-11-21

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc